Illumina inc stock.
Illumina's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $28.30. Hence, Illumina's PS Ratio for today is 3.55. Good Sign: Illumina Inc stock PS Ratio (=3.6) is close to 10-year low of 3.33. The historical rank and industry rank for Illumina's PS Ratio or its related term are showing as below:
Nov 3, 2022 · Illumina Reports Financial Results for Third Quarter of Fiscal Year 2022. Nov 3, 2022. Revenue of $1.12 billion for Q3 2022, up 1% from Q3 2021, and up 3% on a constant currency basis. GAAP diluted loss per share of $ (24.26) for Q3 2022, compared to GAAP diluted earnings per share of $2.08 for Q3 2021; GAAP diluted loss per share for Q3 2022 ... 17 equities research analysts have issued 1 year price targets for Illumina's shares. Their ILMN share price targets range from $100.00 to $328.00. On average, they predict the company's share price to reach $194.56 in the next year. This suggests a possible upside of 77.2% from the stock's current price.Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California, and it serves more than 155 countries. [2] Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. What is Illumina Inc (ILMN)'s stock price today? The current price of ILMN is $97.76. The 52 week high of ILMN is $238.55 and 52 week low is $89.00. When is next earnings date of Illumina Inc (ILMN)?
Find the latest Illumina, Inc. (ILMN) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears.Get the latest Illumina, Inc. (ILMN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
General Inquiries. Salli Schwartz, Vice President lllumina Investor Relations 5200 Illumina Way San Diego, CA 92122. 858.291.6421 [email protected]
Dec 1, 2023 · Find the latest Illumina, Inc. (ILMN) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. 9.12M. BABA. 72.93. -2.60%. 9.87M. View today's Illumina Inc stock price and latest ILMN news and analysis. Create real-time notifications to follow any changes in the live stock price.Find the latest Illumina, Inc. (ILMN) stock quote, history, news and other vital information to help you with your stock trading and investing.Hayward Pool Products Inc is a leading manufacturer of high-quality pool equipment, including pumps, filters, heaters, and cleaners. If you’re lucky enough to own one of their products, it’s important to keep it in good condition to ensure ...0.67%. $6.69B. Invitae Corp. 0.66%. $155.59M. ILMN | Complete Illumina Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Illumina Inc. (Reuters) - A U.S. appeals court on Tuesday said it will accelerate reviewing Illumina Inc's challenge to a federal agency order requiring the biotechnology company to divest cancer ...
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Illumina, Inc. (NASDAQ: ILMN) between May 1, 2023 and October 16, 2023, both dates inclusive (the "Class Period").A class action lawsuit has already been filed. If you wish to serve as lead …
Illumina said on Friday it would divest cancer test maker Grail in 12 months, according to the terms of the European Commission's order, if the life sciences company does not win its challenge in ...This is more than 2x the current stock price of $119.47. Let’s assume Illumina decides to spin-off Grail to shareholders, needs to raise $1 billion in capital, and we choose equity because debt ...The high-performance, long-read, human whole-genome sequencing (WGS) assay – Illumina Complete Long Read Prep, Human – is compatible with Illumina NovaSeq X Plus, NovaSeq X, and NovaSeq 6000 Sequencing Systems. For the first time ever, it offers users access to both long- and short-read data on the same Illumina instrument.Nov 27. Nov 2014 2016 2018 2020 2022 75 100 125 150 175 0 2.5M 5M 7.5M 10M. XNAS:ILMN,NASDAQ:ILMN historical stock data. Stock Date. Stock Price. November 30, 2023. $101.95. November 29, 2023. $101.57.9.66. +0.11. +1.15%. Get Illumina Inc (ILMN:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Illumina might now have to pay a $458mn fine and up to $1.75bn in taxes if it was forced to divest Grail at the same price at which it was purchased, Icahn said. Illumina would be a forced seller ...Illumina, Inc. ( NASDAQ:ILMN – Get Free Report) was the target of a large decline in short interest in October. As of October 31st, there was short interest totalling 5,180,000 shares, a decline of 5.6% from the October 15th total of 5,490,000 shares. Based on an average daily trading volume, of 1,690,000 shares, the short-interest ratio is ...NEW YORK, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Illumina, Inc. ("Illumina" or the "Company") . Such investors are advised to contact ...Weaker Guidance Dragged Illumina (ILMN) in Q3. (Insider Monkey) Nov-16-23 04:50PM. Illumina: Company Investigated by the Portnoy Law Firm. (GlobeNewswire) 10:15AM. Lowey Dannenberg, P.C. is Investigating Illumina, Inc. (NASDAQ: ILMN) for Potential Breaches of Fiduciary Duty by Its Board of Directors. Illumina Inc () Stock Market info Recommendations: Buy or sell Illumina stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Illumina share forecasts, stock quote and buy / sell signals below.According to present data Illumina's ILMN shares and potentially its market environment have been in bearish cycle last 12 …
THE LAWSUIT: A class action securities lawsuit was filed against Illumina, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged …See Illumina, Inc. (ILMN) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California, and it serves more than 155 countries. [2] Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. To learn more, visit illumina.com and connect with us on Twitter, Facebook, LinkedIn, Instagram, and YouTube. Investors: Salli Schwartz 858-291-6421 [email protected]. Media: David McAlpine 347-327-1336. Samantha Beal 714-227-2661 [email protected] DIEGO, Aug. 9, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced Dr. Steven Barnard, Illumina's Vice President and Head of Global Advanced Science, will serve as its next Chief Technology Officer (CTO), effective immediately. Dr. Alex Aravanis, who held the …Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2022. February 7, 2023. Revenue of $1.08 billion for Q4 2022, down 10% from Q4 2021, and down 7% on a constant currency basis. Revenue of $4.58 billion for fiscal year 2022, up 1% from fiscal year 2021, and up 3% on a constant currency basis.Lowe’s is not owned by Walmart or the Walton family. Lowe’s Companies Inc. is a publicly traded company without a majority shareholder. In 2020, The Vanguard Group Inc. held the largest share of Lowe’s stock.U.S. genetic testing company Illumina was fined a record 432-million-euro ($476 million) by the EU on Wednesday for closing its takeover of cancer test maker Grail before securing EU antitrust ...General Inquiries. Salli Schwartz, Vice President lllumina Investor Relations 5200 Illumina Way San Diego, CA 92122. 858.291.6421 [email protected] DIEGO, March 2, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and Myriad Genetics Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the expansion of a strategic partnership to broaden access to and availability of oncology homologous ...By Jorge Diaz. November 30, 2023. Shares of Illumina Inc. (ILMN) showed promising growth on Thursday, closing 0.37% higher at $101.95. This positive performance aligns with the overall success of the stock market, with the S&P 500 Index (SPX) rising 0.38% to 4,567.80 and the Dow Jones Industrial Average (DJIA) surging 1.47% to …
On September 29, 2023, Stifel analyst Daniel Arias expressed his continued optimism for Illumina (NASDAQ:ILMN) by maintaining a Buy rating on the stock. Best stocks to buy now Contact
Jacob Thaysen, PhD is Illumina’s Chief Executive Officer. He joined the company and Board of Directors in September 2023. Prior to Illumina, Jacob was senior vice president of Agilent and president of Agilent's Life Sciences and Applied Markets Group (LSAG) which consists of Agilent's market leading analytical instrument portfolio, informatics and cell …
Nov 29, 2023 · Stock Information. View current and historic stock prices, analyst information, and more. Financial Information. Download quarterly earnings reports, supplementary data, SEC filings, and more. Corporate Governance. Learn about our governance guidelines, code of ethics, Board of Directors, and more. Jul 7, 2023 · Illumina and S&P 500 Performance During 2007-08 Crisis ILMN stock declined from $87 in August 2008 (its pre-crisis peak) to around $31 in March 2009 (as the markets bottomed out), implying that it ... General Inquiries. Salli Schwartz, Vice President lllumina Investor Relations 5200 Illumina Way San Diego, CA 92122. 858.291.6421 [email protected] historical prices for ILMN stock on Yahoo Finance. View daily, weekly or monthly format back to when Illumina, Inc. stock was issued. ... Illumina, Inc. (ILMN) NasdaqGS - NasdaqGS Real ... THE LAWSUIT: A class action securities lawsuit was filed against Illumina, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged …U.S. genetic testing company Illumina was fined a record 432-million-euro ($476 million) by the EU on Wednesday for closing its takeover of cancer test maker Grail before securing EU antitrust ...Overall, Revvity Inc stock has a Growth Score of 90, Momentum Score of 36 and Quality Score of 68. Illumina, Inc. stock has a Growth Score of 90, Momentum Score of 17 and Quality Score of 49. Comparing Revvity Inc, Illumina and Inc.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not.Nov 16, 2023 · Illumina, Inc. Stock Price History. Illumina, Inc.’s price is currently down 13% so far this month. During the month of November, Illumina, Inc.’s stock price has reached a high of $118.38 and a low of $89.00. Over the last year, Illumina, Inc. has hit prices as high as $238.71 and as low as $89.00. Year to date, Illumina, Inc.’s stock is ...
Nov 29, 2023 · Delivering Value to Investors. A global leader in DNA sequencing and array-based technologies, Illumina is fueling advancements in life sciences, oncology, reproductive health, genetic disease, agriculture, microbiology, and other emerging segments. We are dedicated to improving human health by unlocking the power of the genome. On June 6, Illumina Inc (ILMN) had a median target price of $232.50, with a high estimate of $336.00 and a low estimate of $150.00. This represents a +13.02% increase from the last price of $205.72. The company’s stock has been performing well, with a consensus among 21 polled investment analysts to buy stock in Illumina Inc.Dec 5, 2023 · Illumina Inc (NASDAQ: ILMN)’s stock price has gone rise by 4.14 in comparison to its previous close of 109.79, however, the company has experienced a 20.80% increase in its stock price over the last five trading days. Seeking Alpha reported 2023-11-29 that Illumina, Inc. (NASDAQ:ILMN ) Piper Sandler 35th Annual Healthcare Conference November 29, 2023 […] Instagram:https://instagram. catastrophic health insurance over 50indices brokers in usabest financial planning software for financial advisorsbest book on investing for beginners NSD:ILMN Detailed Stock Analysis, Stock Price Forecast, Analyst Ratings, Financial Analysis, Stock News & Historic QuotesApr 25, 2023 · SAN DIEGO, April 25, 2023 /PRNewswire/ -- Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the first quarter of fiscal year 2023, which include the consolidated financial results for GRAIL. etf with nvidiaotcmkts ptraq The average price predicted for Illumina Inc (ILMN) by analysts is $136.31, which is $38.7 above the current market price. The public float for ILMN is 158.12M, and at present, short sellers hold a 3.27% of that float. On November 21, 2023, the average trading volume of ILMN was 2.01M shares. ILMN) stock’s latest price […]On this news, the Company’s stock price fell $7.42, or 5.6%, to close at $124.45 per share on October 18, 2023. What Now: Similarly situated shareholders may be eligible to participate in the class action against Illumina, Inc. Shareholders who want to act as lead plaintiff for the class should contact Robbins LLP. Plaintiffs must file their ... free stock screeners The low in the last 52 weeks of Illumina stock was 89.01. According to the current price, Illumina is 122.47% away from the 52-week low. What was the 52-week high for Illumina stock?Sep 21, 2020 · GRAIL stockholders excluding Illumina will receive approximately 9.9 million Illumina shares if the 20-trading-day volume weighted average price of Illumina stock as of 10 trading days prior to closing is above $399 and approximately 13.4 million Illumina shares if the 20-trading-day volume weighted average price of Illumina stock as of 10 ...